Research To Practice | Oncology Videos Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 2
Aug 3, 2022
01:02:22
Featuring perspectives from Dr Ursula Matulonis, including the following topics:
- Introduction: Journal Club with Ursula Matulonis, MD — Part 1 (0:00)
- Case: A woman in her late 60s with primary peritoneal carcinoma with a germline BRCA mutation who underwent naturopathic therapy — Dana M Chase, MD (31:08)
- Case: A woman in her late 70s with Stage IIIC fallopian tube cancer (homologous recombination proficient [HRp]) who underwent neoadjuvant chemotherapy — Paul DiSilvestro, MD (33:55)
- Case: A woman in her late 60s with high-grade serous ovarian carcinoma and extensive peritoneal and omental metastases (HRp) who received chemotherapy and bevacizumab followed by niraparib — Vikas Malhotra, MD (38:50)
- Case: A woman in her mid 70s with a germline BRCA1 mutation and bilateral breast cancer who experiences a complete response for 8 years to chemotherapy for metastatic ovarian cancer — Bruce Bank, MD (46:38)
- Faculty Survey (49:46)
- Journal Club with Dr Matulonis — Part 2 (54:02)
- Case: A woman in her mid 40s who experienced multiple relapses of microsatellite instability-high clear cell ovarian cancer — Syed F Zafar, MD (57:38)